Рубрика
Blog
-
2023
-
FDA Advisors Reject Cytokinetics’ Heart Failure Candidate
-
Merck and Moderna’s mRNA cancer vaccine aces its first efficacy trial
-
Rare Disease Moonshot launched at European Health Summit
-
Mirati’s Krazati Gets Accelerated Approval for NSCLC
-
British Pharma Industry Cites Six Companies for Code Violations
-
ASH: CD20 bispecific antibodies take centre stage in lymphoma
-
Moleculin Biotech’s WP1122 Receives Fast Track Status for Glioblastoma
-
The Effect of Aging in Multiple Sclerosis and the Model of Care
-
SABCS: Pharmas show their working in HR+/HER2- breast cancer
-
Istesso’s Idiopathic Pulmonary Fibrosis Candidate Gains Fast Track